 | • レポートコード：MRC2108A332 • 出版社/出版日：Mordor Intelligence / 2021年7月31日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、医療機器の世界市場規模が2020年5,048.5億ドルから2026年6,294.0億ドルまで、2021年から2026年の間に年平均5.71％成長すると予測しています。本調査資料では、世界の医療機器市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、機器別（呼吸機器、心臓病機器、整形外科機器、画像診断機器、内視鏡機器、その他）分析、地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・医療機器の世界市場規模：機器別（呼吸機器、心臓病機器、整形外科機器、画像診断機器、内視鏡機器、その他） ・医療機器の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Abbott Laboratories Inc、Boston Scientific Corporation、F. Hoffmann-La Roche Ltd、GE Healthcare (GE Company)、Johnson & Johnson、Medtronic PLC、Koninklinje Philips NV、Siemens Healthineers (Siemens AG)、Smith & Nephew PLC、Stryker Corporation、Fresenius Medical Care AG & Co. KGaA、3M Company、Cardinal Health Inc.） ・市場機会/将来の見通し |
The medical devices market was estimated to be USD 504.85 billion in 2020 and is expected to witness a CAGR of around 5.71% over the forecast period to reach USD 629.40 billion in the year 2026. The COVID-19 pandemic is expected to have a mixed impact on the market. Currently, countries are facing the huge threat of the COVID-19 pandemic. There is a shortage of treatment available against this type of disease and most of the pharmaceutical and biotechnological companies are focusing their research and development departments in identifying new molecules or leads for the treatment of this disease. The supply chain disruption caused due to Covid-19 has led to shortages of critical medical devices across the globe. Therefore, many countries have taken definite measurements in order to ease the shortages by importing equipment such as domestic manufacturing of medical devices.
In addition to, domestic manufacturing of essential medical devices is expected overcome trade barriers, at the same time ensure product quality and market stability. However, instances of counterfeiting and price gouging of imported medical equipment is expected to hamper the market growth. According to the data given on United States FDA (United States Food & Drug Administration), in August 2020, FDA recalled the TaqPath RT-PCR COVID-19 Kit with Applied Biosystem’s COVID-19 Interpretive Software v1.2 for 7500 RTPCR instruments developed by Life Technologies Corporation due to the false positive results because of the improper vortexing. While some of the medical devices experienced a sudden surge in the demand during this period. For instance, ventilators are in high demand for COVID – 19 patients as they are an important tool in hospitals that can keep the patients in critical conditions alive. In March 2020, Medtronic announced that it had increased production of ventilators by more than 40% to date and is on track to more than double its capacity to manufacture and supply ventilators in response to the urgent needs of patients and healthcare systems across the world confronting COVID-19
The factors that are driving the market growth include the rising prevalence of chronic diseases and related increases in disability-adjusted life years, technological advancements in medical devices, and a consistent increase in the aging population.
The proportion of older population and the length of life expectancy has also increased throughout the world. This is expected to have significant impact on the healthcare system and thereby positively impact on the global medical devices market growth. According to the World Ageing Population report, in 2019, around 703 million people aged 65 years and above were living all across the world. Over the next three decades, this number of older population is expected to increase more than double, over 1.5 billion by the year 2050. Majority share of the older population is contributed by Eastern and South Eastern Asia followed by Europe and North America, according to the above-mentioned source. Thus, due to increase in the geriatric population, health and long-term care expenditures are expected to increase sharply. Older population is often susceptible to hearing loss, cataracts and refractive errors, back and neck pain and osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, and dementia. This is expected to boost the market growth for medical devices.
Furthermore, the advent of new technology in the market is expected to increase demand for medical devices. Companies like ABLE Motion are bringing in new innovation into the sector. For example, this Barcelona-based company was the world’s first manufacturer of home-use robotic exoskeletons for individuals with lower-limb paralysis. The battery-powered, 8 kg exoskeleton has parameters for smart device configurations, allowing for physical therapists and physicians to remote monitor patients. Garwood Medical, a Buffalo, New York-based MedTech startup provides clinical outcomes for infections and wound healing. The company’s range of products include the BioPrax, a minimally invasive device designed to prevent biofilm infections on prosthetic knee implants by using electrodes to prevent microbe growth. Signum Surgical, a Galway, Ireland-based MedTech startup, has developed innovative implant technologies to promote post-surgery healing and prevent infection in colorectal patients. In the future, Signum Surgical hopes to expand its range of products to treat other colorectal disease conditions.
Additionally, chronic diseases are the most prevalent health condition that involves significant expenditure globally. Chronic diseases include cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, and obesity that can lead to hospitalization, long-term disability, reduced quality of life, and even death. According to the International Diabetes Federation, approximately 463 million adults of age between 20-79 years were living with diabetes in 2019 and is estimated to rise to 700 million by 2045 globally. According to Arthritis-India, Osteoarthritis (OA) affects about 4-6% of adult population and is mentioned as one of the top 5 chronic diseases in India and the country is likely to notice an endemic of osteoarthritis with about 80 percent of the 65 and above population in the country suffering with wear and tear of joints by 2025. Furthermore, according to the study published in Lancet, in 2018, around 1.2 million people died across the world due to chronic kidney diseases and about 697.5 million of chronic kidney diseases patients were recorded globally. Thus, with the growing burden of chronic diseases the demand for medical devices is also expected to rise sharply and thereby accelerate the market growth during the forecast period.
Hence all these factors indicates the rising demand for devices required for diagnosis, treatment, monitoring and management of the diseases.
Key Market Trends
Cardiology Devices Segment is Expected to Hold a Major Market Share in the Medical Device Market
Cardiovascular devices are used to diagnose and treat heart disease and related health problems that are leading causes of death worldwide. There are three basic types of cardiology devices, namely diagnostic and monitoring devices, therapeutic and surgical devices. Some of the widely used cardiovascular devices are electrocardiogram (ECG), defibrillators, pacemakers, cardiac rhythm management devices, catheter, grafts, heart valves, and stents. The major factors driving the growth of the cardiology devices segment are the rising global prevalence of various coronary heart diseases, such as stroke and cardiomyopathy, which cause a global burden of cardiac deaths. According to the article, ‘Prevalence of Cardiovascular Disease in Adults’, published in February 2020 in the US Pharmacist, in 2018, 30.3 million adults (12.1%) in the United States were diagnosed with cardiovascular diseases. Circulatory diseases place a heavy financial burden on individuals and healthcare systems. As per the 2018 white paper of Global Coalition for Circulatory Health, by 2030, the total global cost of cardiovascular diseases is set to rise from approximately USD 957 billion in 2015 to USD 1,044 billion by 2030. There are many products being launched in the market currently. In October 2019, iRhythm, a digital healthcare company, launched its Zio system in the United Kingdom to support the identification and clinical diagnoses of cardiac arrythmias, such as atrial fibrillation (AF). The Zio system is a small wearable heart monitor that attaches to the patient’s chest for a period of up to 14 days. In May 2019, AliveCor received the US FDA’s approval for KardiaMobile 6L, the first six-lead personal ECG device that uses a form factor to gather maximum information. The increase in number of elderly population is also leading to a spurt in the number of cardiovascular diseases as this demographic cohort is more susceptible to these disorders.
North America Dominates the Market and is Expected to Continue the Same during the Forecast Period
The primary growth driver of the medical devices market in the North American market is the higher investment of yearly revenues into product innovation and constant improvement of existing technologies. Mobile health and telemedicine have been growing in the United States, with an increasing rate of adoption. The United States in the largest market the North American region.
The medical devices sector in the United States is an important part of the healthcare industry. Moreover, the market has a very competitive landscape, with the presence of leading medical device market players, such as Johnson and Johnson, Abbott, and Baxter International. According to the International Agency for Research on Cancer in 2020, about 2,281,658 new cases of cancer were diagnosed in 2020, including 209,512 cases of prostate cancer, 253,465 cases of breast cancer, 227,875 cases of lung and bronchus cancer, and 101,809 cases of colorectal cancer. Furthermore, the majority of the medical device market players are small- and medium-sized companies with huge innovations and supported funding. Also, the advent of technological advancements, such as 3D printing, artificial intelligence, and robotic surgery devices and their adoption are likely to further boost the market growth. In August 2020, Utah-based Innovasis Inc. announced that the US Food and Drug Administration (FDA) gave 510(k) clearance for use of its Bio-enhanced 3D printed AxTiHA and TxTiHA Interbody Fusion Devices that have been modified with Promimic HAnano Surface technology. IDx-DR, an advanced Artificial Intelligence-based diagnostic system that autonomously diagnoses patients for diabetic retinopathy and macular edema, was approved by the US Food and Drug Administration in 2018. It is first of its kind for using the AI system for diagnosis of indications.
Competitive Landscape
The medical devices market is fragmented competitive and consists of a number of major players. Companies, like Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Philips Healthcare, Siemens Healthineers(Siemens AG), Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Medtronic PLC, Smith & Nephew PLC, and GE Healthcare, among others, hold the substantial share in the market studied. Many of these companies are undertaking various strategies to maintain their market share. For example, in October 2020, Medtronic PLC entered into a partnership with The Foundry, a medical device company. The partnership combines Medtronic’s leadership in Structural Heart and intellectual property with The Foundry’s track record of innovation in the field of transcatheter mitral valve repair and replacement.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Geriatric Population across the World
4.2.2 Rising Prevalence of Chronic Diseases and Related Increase in Disability-adjusted Life Years
4.3 Market Restraints
4.3.1 Strict Regulatory Polices and Uncertainty in Reimbursement
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Type of Device
5.1.1 Respiratory Devices
5.1.2 Cardiology Devices
5.1.3 Orthopedic Devices
5.1.4 Diagnostic Imaging Devices (Radiology Devices)
5.1.5 Endoscopy Devices
5.1.6 Ophthalmology Devices
5.1.7 Other Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories Inc
6.1.2 Boston Scientific Corporation
6.1.3 F. Hoffmann-La Roche Ltd
6.1.4 GE Healthcare (GE Company)
6.1.5 Johnson & Johnson
6.1.6 Medtronic PLC
6.1.7 Koninklinje Philips NV
6.1.8 Siemens Healthineers (Siemens AG)
6.1.9 Smith & Nephew PLC
6.1.10 Stryker Corporation
6.1.11 Fresenius Medical Care AG & Co. KGaA
6.1.12 3M Company
6.1.13 Cardinal Health Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS